Closed & Collaborative H2 2025: Mergers, acquisitions, partnerships, collaborations, and strategic agreements The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.

#RNA #ADCs #earlyphaseclinicalservices #biosimilars #marketentry #platformlicensing #Radiopharmaceuticals #hospitalAI #CDxpartnerships #genomicsequencing #biomarkerdiscovery #Digitalhealth #biologics #specialtymedicines #precisionmedicine #MandA #licensingagreements
zurl.co/ch3Xg

Updating old standards for a new age. New consensus recommendations help guide the future of #newborn #screening. bit.ly/4ojFAjA #Genomicsequencing #DelphiTechnique #ICoNS

Celebrating World AMR Week 20205: How GenPath Africa is using genomic sequencing to fight drug-resistant TB   — GenPath Africa During this year’s World AMR Awareness Week, PARR-TB study co-leads Annelies van Rie (University of Antwerp) and Rob Warren (Stellenbosch University) discuss how GenPath Affrica is harnessing genomic ...

🌍💊#WAAW2025 highlight – #GenPathAfrica

In a new interview, Prof Annelies van Rie and Prof Rob Warren share how GenPath Africa’s PARR-TB study harnesses #GenomicSequencing to combat the growing threat of drug-resistant #TB.

🎥Watch here: tinyurl.com/4y7pmn42

@globalhealthedctp3.bsky.social

In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome | Newswise About a dozen studies in the past five years have made claims linking nearly every type of human cancer with the presence of microbiomes, “communities” of bacteria, viruses and fungi that live in or o...

In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome
www.newswise.com/articles/in-...
#Microbiome #cancer #cancerawareness #genomicsequencing #CancerDiagnostics

One Pill, Two Pills, Tailored Just for You — The Cancer Revolution That’s Actually Clever Welcome to a future where chemo might finally stop behaving like a drunk octopus wielding a chainsaw.

Welcome to a future where chemo might finally stop behaving like a drunk octopus wielding a chainsaw!
.
#column #tumours #cancer #chemo #cancertreatment #chemotherapy #genomicsequencing #dna #immunesystem #cancerpatient #cancersurvivor #cancer #ddod
.
www.dailydoseofdisbelief.com/one-pill-two...

One Pill, Two Pills, Tailored Just for You — The Cancer Revolution That’s Actually Clever Welcome to a future where chemo might finally stop behaving like a drunk octopus wielding a chainsaw.

Welcome to a future where chemo might finally stop behaving like a drunk octopus wielding a chainsaw!
.
#column #tumours #cancer #chemo #cancertreatment #chemotherapy #genomicsequencing #dna #immunesystem #cancerpatient #cancersurvivor #cancer #ddod
.
www.dailydoseofdisbelief.com/one-pill-two...

When is #GenomicSequencing useful in the NICU? The Clinician-reported Genetic testing Utility InDex (C-GUIDE) NICU can help assess its clinical utility. bit.ly/3UANXuE

Twelve key takeaways from Labour’s 10-year NHS plan Ministers hope to revolutionise digital access to records and services, with more focus on prevention and local services

#NHS #NHS10yearplan #diseaseprevention #NHSapp #AI #NHSStructuralchanges #neighbourhoodhealthservices #MyNHSGP #Patientleaguetables #MyChoices #NHSdata #AI #genomicsequencing #personalhealthbudget #Communityhealthhubs #integratedcare #patientaccess #NHSstaff
www.theguardian.com/society/2025...

New paper! @hadleyssmith.bsky.social and team's paper An end to #genetic exceptionalism: reframing the #ethics of #genomicsequencing for rapid #neonatal #diagnosis is featured in Semin Perinatol!

Read More Here: buff.ly/Zh7Js2G

ZIPcnv: accurate and efficient inference of copy number variations from shallow whole-genome sequencing
Jin, X., Lai, X. et al.
Paper
Details
#ZIPcnv #CopyNumberVariations #GenomicSequencing

A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice - Communications Medicine Chung et al. examine the multi-dimensional effectiveness of genome sequencing and summarise indicators and measurement tools for psychosocial and economic outcomes. They highlight priority areas for outcome-oriented research and showcase best practices in selecting outcome measures for effective implementation within genome projects.

🚨 NEW PERSPECTIVE! ⚕️ 🩺

Chung et al. summarise indicators and measurement tools for psychosocial and economic outcomes from genomic sequencing projects.

https://bit.ly/3TiaYCh #GenomicSequencing #PsychosocialResearch #OutcomeMeasures

New research has uncovered millions of hidden mutations in childhood kidney cancer tissue caused by Wilms tumour. Dr Stephanie Santos Paulo writes more in BioNews: www.progress.org.uk/genomics-res...

#genomics #Wilmstumour #cancer #genomicsequencing #duplexsequencing #genetics #DNA

#auspol #COVID19 #genomicsequencing

Genomic test identifes rare bacterial eye infection in patient | PET A novel approach called 'metagenomics' screens for all possible pathogens simultaneously, rather than looking for a specific bacteria or virus.

A mystery bacterial eye infection, that affected a woman for 5yrs was identified using a novel genomic test that led to targeted treatment and full recovery. Rumi Georgieva writes more in BioNews: www.progress.org.uk/genomic-test...

#genomics #genomicsequencing #DNA #personalisedmedicine

Algorithm to revolutionise cancer detection | National Health Executive Researchers have unveiled a groundbreaking 'metal detector' algorithm, PRRDetect, which could revolutionise cancer treatment by

#GenomicMedicine #genomics #oncology #genomeresearch #NIHR #metaldetectoralgorithm #PRRDetect #DNAsequence #GenomicsEngland #100000GenomesProject #personalisedtreatment #immunotherapy #Genomicsequencing #tumoursequencing #DNAsequence
www.nationalhealthexecutive.com/articles/alg...

COMMENT: 23andMe: a salutary tale
Dr Pete Mills, PHG Foundation Director, documents the rise and fall of 23andMe in BioNews
Read the full comment piece here: www.progress.org.uk/23andme-a-sa...

#DNA #ancestry #genetics #genomics #genomicsequencing

#278 DNA Dialogues: Rare Disease Family Experience — DNA Today New podcast launch! Check out the first episode of the official Journal of Genetic Counseling Podcast, “DNA Dialogues”.

Did you know March is #NationalTrisomyAwarenessMonth? 🧬🧬🧬

Tune into our #sciencepodcast episode where we talk about pediatric access to care after #genomicsequencing ⤵️

dnapodcast.com/episodes/202...

#genetics

Understanding Bacterial Vaginosis: A Paradigm Shift in STI Treatment for Women Recent scientific advancements have transformed our understanding of sexual health, bringing to light the important classification of bacterial vaginosis (BV) as a sexually transmitted infection (STI). This revelation affects nearly one in three women worldwide and demands a reconsideration of conventional treatment methods. Bacterial Vaginosis: A Common Yet Misunderstood Infection Bacterial vaginosis is a prevalent condition that has long been misconstrued.

READ FULL ARTICLE ON WOMAN'S HEALTH ON WEBSITE: #BacterialVaginosis #SexualHealth #STIs #WomensHealth #ReproductiveHealth #HealthAwareness #MedicalResearch #PartnerTreatment #PatientEducation #Healthcare #Infertility #GenomicSequencing #MelbourneSexualHealth #HealthInnovation #PublicHealth

Screenshot of text that reads: Challenge 2: Disaggregation and sourcing of resource use and unit prices The disaggregation of costs requires a comprehensive mapping of the entire sequencing process. Clinical ES and GS involve multiple stages that may be carried out by different laboratory departments or even outsourced to third parties, as is the case with sequencing. This complicates the identification of appropriate unit costs and resource use items for measurement and valuation. Simply aggregating cost data from various sources might not be reliable if differences in protocols and associated resources utilized between various laboratories are not considered. Accurately measuring costs requires detailed delineation of the sequencing workflow to include all stages, from preanalytic sample collection to postanalytic generation of the test report. This should reflect all steps and work teams involved, accounting for factors such as sample processing volumes, sequencing methods, equipment, and validation procedures, indicating when steps are outsourced and how these were costed (eg, market price or supplier-negotiated prices). This approach better reflects practice across laboratory departments and providers, resulting in a more accurate estimation of costs and resources.

Are #GenomicSequencing costs actually decreasing? #Microcosting studies are vital for understanding the economic cost, but challenges persist in quality, consistency, and comparability of studies bit.ly/4fVHC5t #HealthcareEconomics